XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income (loss) $ 380,190 $ (2,255,074)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,339,225 1,428,934
Stock compensation 280,981 301,547
Bad debt expense 13,416 0
Loss (Gain) on sale of real estate assets, net (1,522,785) 1,161,328
Gain on extinguishment of government debt 0 (10,000)
Net change in fair value marketable securities 68,962 0
Impairment of real estate assets 0 300,000
Amortization of financing costs 65,018 261,779
Amortization of above-market leases 0 18,027
Amortization of below-market leases (13,723) (19,037)
Straight-line rent adjustment (19,660) (132,990)
Changes in operating assets and liabilities:    
Other assets 295,357 481,459
Accounts payable and accrued liabilities (1,330,285) (1,980,474)
Accrued real estate taxes (534,956) (1,023,680)
Net cash used in operating activities (978,260) (1,468,181)
Cash flows from investing activities:    
Real estate acquisitions (2,427,890) 0
Additions to buildings and tenant improvements (319,737) (100,765)
Investment in marketable securities (172,866) 0
Proceeds from sale of marketable securities 755,989 0
Investment of SPAC IPO proceeds into Trust Account (134,895,000) 0
Additions to deferred leasing costs (18,352) (37,585)
Proceeds from sales of real estate, net 14,763,130 19,047,906
Net cash provided by (used in) investing activities (122,314,726) 18,909,556
Cash flows from financing activities:    
Proceeds from mortgage notes payable, net of issuance costs 7,365,855 6,013,700
Repayment of mortgage notes payable (3,275,234) (17,231,730)
Repayment of note payable 0 (7,675,598)
Payment of deferred offering costs (3,159,411) (70,276)
Distributions to noncontrolling interests, net (258,410) (2,034,212)
Proceeds from initial public offering of SPAC 132,250,000 0
Dividends paid to preferred stockholders (539,056) 0
Dividends paid to common stockholders (1,298,252) (998,795)
Net cash provided by (used in) financing activities 131,085,492 (21,996,911)
Net increase (decrease) in cash equivalents and restricted cash 7,792,506 (4,555,536)
Cash, cash equivalents and restricted cash - beginning of period 14,702,089 11,540,917
Cash, cash equivalents and restricted cash - end of period 22,494,595 6,985,381
Non-cash financing activities:    
Deferred offering cost SPAC, underwriting commission payable 4,628,750 0
Dividends payable - Preferred Stock Series D 179,685 0
Mortgage Notes [Member]    
Supplemental disclosure of cash flow information:    
Interest paid 951,727 1,239,193
Notes Payable [Member]    
Supplemental disclosure of cash flow information:    
Interest paid $ 0 $ 103,861